Abstract:N6-methyladenosine (m6A) is the most abundant and conserved transcriptional modification in eukaryotic RNA, regulating RNA fate. While the functions of m6A in the development of the mammalian brain have been extensively studied, its roles in synaptic plasticity, cognitive decline, motor function, or other brain circuits remain underexplored. To date, the role of this modification in Parkinson's disease (PD) and other synucleinopathies has been largely unknown. Here, we investigated the m6A epitranscriptome in a mouse model of synucleinopathy. We performed m6A RNA immunoprecipitation sequencing (meRIP-seq) to obtain the m6A epitranscriptome of the midbrain in young (3 mo) and aged (15 mo) A30P-aSyn transgenic mice (aSyn Tg) and C57BL6 control wild type (Wt) mice. We observed hypermethylation of synaptic genes in 3 mo aSyn Tg mice compared to age-matched Wt mice. This methylation was reduced during ageing, with synaptic genes becoming increasingly hypomethylated. Using immunofluorescence imaging alongside biochemical analysis, we further investigated the expression of m6A regulatory enzymes writer, N6-Adenosine-Methyltransferase Complex Catalytic Subunit (METTL3); reader, YTH N6-methyladenosine RNA-binding protein (YTHDF1); and eraser, fat mass and obesity-associated protein (FTO) in the cortex, striatum, hippocampus, and cerebellum of Wt and aSyn Tg mice, as well as in primary cortical neuronal cultures. We observed that the levels of METTL3, YTHDF1 and FTO were similar between Wt and aSyn Tg mice. Interestingly, the writer protein METTL3 was found in both the nucleus and in the post-synaptic compartment in neuronal cultures. Our findings suggest that alterations in the regulation of m6A RNA methylation may be associated with neurodegeneration and ageing and that this level of epitranscriptomic regulation plays a significant role at the synapse.

Epitranscriptomics: new players in an old game.

Aging through an epitranscriptomic lens

Dysregulated RNA processing and metabolism: a new hallmark of ageing and provocation for cellular senescence

Ageing-associated changes in transcriptional elongation influence longevity

Meta-analysis of the transcriptome identifies aberrant RNA processing as common feature of aging in multiple species

Regulation and roles of RNA modifications in aging‐related diseases

A post-transcriptional regulatory landscape of aging in the female mouse hippocampus

Unraveling aging from transcriptomics

Genetic regulation of gene expression and splicing during a 10-year period of human aging

RNA Modifications Shape Hematopoietic Stem Cell Aging: Beyond the Code

MicroRNAs as Mediators of the Ageing Process

The landscape of the alternatively spliced transcriptome remains stable during aging across different species and tissues

The epitranscriptomic m6A RNA modification modulates synaptic function in ageing and in a mouse model of synucleinopathy

Systematic transcriptome analysis associated with physiological and chronological aging in Caenorhabditis elegans

Full-length direct RNA sequencing reveals extensive remodeling of RNA expression, processing and modification in aging Caenorhabditis elegans

Single-cell analysis of the epitranscriptome: RNA modifications under the microscope

Comprehensive transcriptome analysis reveals altered mRNA splicing and post-transcriptional changes in the aged mouse brain

Noncoding RNAs and Epigenetic Regulation in Aging

Translation is an emerging constraint on protein homeostasis in ageing

The epitranscriptome: RNA modifications in vascular remodelling

Epigenetic Reprogramming as a Key to Reverse Ageing and Increase Longevity